SUPREME CANNABIS Profile

Performance

   

Odds of Distress

Check how we calculate scores
Equity ratings for SUPREME CANNABIS INC are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 23, 2019 and ending today August 22, 2019. Click here to learn more.
1.03
USD 0.07  6.36%

SUPREME CANNABIS INC Risk Profiles

SUPREME CANNABIS Key Fundamentals

SUPREME CANNABIS Against Markets

The Supreme Cannabis Company, Inc. engages in the production of medical cannabis in Canada. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada. SUPREME CANNABIS operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 270 people. more
NameSUPREME CANNABIS INC
CEOJohn FowlerView All
Thematic Classification
Currently Active Investing Idea
  Marijuana
View All
Macroaxis Advice
InstrumentUSA OTC Stock View All
Business Address178R Ossington Avenue
ExchangeBATS Exchange
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.supreme.ca
Phone416 630 7272
CurrencyUSD - US Dollar
Next Fiscal Year EndJune 30, 2020
Most Recent QuarterMarch 31, 2019
Last Fiscal Year EndJune 30, 2018

SUPREME CANNABIS Corporate Directors

Chris Bechtel Director
Navdeep Dhaliwal Director
Ron Factor Director
Also please take a look at World Market Map. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.
Search macroaxis.com